国产bbaaaaa片,成年美女黄网站色视频免费,成年黄大片,а天堂中文最新一区二区三区,成人精品视频一区二区三区尤物

首頁> 美國衛(wèi)生研究院文獻(xiàn)>Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine >Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD) Delayed Sleep-Wake Phase Disorder (DSWPD) Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD) and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline
【2h】

Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD) Delayed Sleep-Wake Phase Disorder (DSWPD) Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD) and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline

機(jī)譯:治療內(nèi)在晝夜節(jié)律睡眠障礙的臨床實(shí)踐指南:先進(jìn)的睡眠喚醒期疾病(ASWPD)延遲睡眠術(shù)后疾?。―SWPD)非24小時(shí)睡眠節(jié)奏障礙(N24WD)以及不規(guī)則的睡眠喚醒節(jié)奏障礙(ISWRD)。 2015年的更新:美國睡眠醫(yī)學(xué)院臨床實(shí)踐指南

代理獲取
本網(wǎng)站僅為用戶提供外文OA文獻(xiàn)查詢和代理獲取服務(wù),本網(wǎng)站沒有原文。下單后我們將采用程序或人工為您竭誠獲取高質(zhì)量的原文,但由于OA文獻(xiàn)來源多樣且變更頻繁,仍可能出現(xiàn)獲取不到、文獻(xiàn)不完整或與標(biāo)題不符等情況,如果獲取不到我們將提供退款服務(wù)。請(qǐng)知悉。

摘要

A systematic literature review and meta-analyses (where appropriate) were performed and the GRADE approach was used to update the previous American Academy of Sleep Medicine Practice Parameters on the treatment of intrinsic circadian rhythm sleep-wake disorders. Available data allowed for positive endorsement (at a second-tier degree of confidence) of strategically timed melatonin (for the treatment of DSWPD, blind adults with N24SWD, and children/ adolescents with ISWRD and comorbid neurological disorders), and light therapy with or without accompanying behavioral interventions (adults with ASWPD, children/adolescents with DSWPD, and elderly with dementia). Recommendations against the use of melatonin and discrete sleep-promoting medications are provided for demented elderly patients, at a second- and first-tier degree of confidence, respectively. No recommendations were provided for remaining treatments/ populations, due to either insufficient or absent data. Areas where further research is needed are discussed.
機(jī)譯:進(jìn)行了系統(tǒng)的文獻(xiàn)綜述和薈萃分析(適當(dāng)?shù)牡胤剑?,使用?jí)別方法來更新以前的美國睡眠醫(yī)學(xué)實(shí)踐參數(shù),以治療內(nèi)在的晝夜節(jié)律睡眠障礙障礙。可用的數(shù)據(jù)允許具有戰(zhàn)略定時(shí)褪黑激素的積極認(rèn)可(以二線置信度)(用于治療DSWPD,與N24SWD的盲人成人,以及具有ISWRD和共用神經(jīng)系統(tǒng)疾病的兒童/青少年),以及有或沒有的光療法隨行的行為干預(yù)(成年人有Aswpd,兒童/青少年的Dswpd和老年人患有癡呆癥)。針對(duì)使用褪黑激素和離散睡眠促進(jìn)藥物的建議,分別為癡呆的老年患者,分別為第二款和一系列的置信度。由于數(shù)據(jù)不足或缺席,未提供剩余治療/人群的建議。討論了進(jìn)一步研究的地區(qū)。

著錄項(xiàng)

相似文獻(xiàn)

  • 外文文獻(xiàn)
  • 中文文獻(xiàn)
  • 專利
代理獲取

客服郵箱:kefu@zhangqiaokeyan.com

京公網(wǎng)安備:11010802029741號(hào) ICP備案號(hào):京ICP備15016152號(hào)-6 六維聯(lián)合信息科技 (北京) 有限公司?版權(quán)所有
  • 客服微信

  • 服務(wù)號(hào)